Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Biases in Animal Studies may Differ from those in Clinical Trials

Published: Tuesday, January 28, 2014
Last Updated: Tuesday, January 28, 2014
Bookmark and Share
New analysis of animal studies on cholesterol-lowering statins found that non-industry studies had results that favored the drugs even more than studies funded by industry.

The analysis of 63 animal studies of statins, was led by Lisa Bero, PhD, UCSF professor clinical pharmacy.

In previous studies, Bero determined that drug-company-sponsored clinical trials were associated with publication of outcomes that favor the sponsor. Bero’s work has been cited as part of policy reform efforts that have led many journal publishers, agencies and institutions to require researchers to disclose funding sources and possible conflicts of interest when presenting their research.

The impetus for the current study, Bero said, was to explore whether or not industry-funded animal studies also would be likely to yield more positive outcomes for the companies’ drug candidates.
But in their analysis the researchers found the opposite: Results of animal studies that had industry sponsorship were less likely to measure a benefit for statins in slowing or preventing arterial disease. Of the studies that disclosed funding, 9 of 19 industry-sponsored studies had results that favored statins, in comparison to 18 out of 28 studies that favored statins among studies not funded by industry.

The explanation may be, said Bero, that “the interests of the pharmaceutical industry might be best served by underestimating efficacy prior to clinical trials, and overestimating efficacy in clinical trials. By underestimating efficacy in preclinical studies, the pharmaceutical industry could reduce the money spent on clinical trials that did not lead to marketable products.”

“Because demonstrating drug efficacy in human studies is linked to drug company profits, drug companies may have more incentive to publish favorable efficacy findings of human drug studies than animal studies.”

However, the reason for the opposite findings obtained in analyzing animal and human studies merits additional investigation, Bero said. Selective reporting of study outcomes might play a role, she suggested.

Conclusions of all the studies tended to be favorable in Bero’s PLoS Biology analysis. While the industry-sponsored animal studies had somewhat less favorable results, they nonetheless were more likely to present conclusions that favored the statin even when data were less favorable. This result highlights the role of “spin” in communicating research findings, Bero said.

The UCSF researchers also found methodological problems to be common, both in non-industry and industry-sponsored studies. Furthermore, Bero found that harmful side effects were not investigated.

“Not a single animal study we looked at assessed adverse events following the statin intervention,” Bero said. “As toxicity data from animal studies must be submitted to drug regulatory authorities before a compound can proceed to testing in humans, it is surprising that so little data on harm appear in the published scientific literature.”

In about half the studies analyzed, it appeared that animals were not assigned to treatment or placebo arms of the study randomly, a requirement of high-quality clinical trials. Furthermore, in about half the animal studies analyzed animals were identifiable to the person assigning treatment, a violation of the practice of “blinding.”

Criteria for including or excluding animals from studies often were not included in published reports, the UCSF researchers found, and many studies also failed to account properly for changes in the assigned treatment arm that occurred during the course of treatment.

Most of the industry and non industry studies analyzed in Bero’s PLoS Biology report were done using rabbits and mice. To gauge atherosclerosis, targeted by statins, researchers quantified blood vessel qualities such as number of damaged blood vessels, blood-vessel diameter, plaque severity, blockage to coronary and other arteries, and plaque rupture.

The study was funded by the National Institute of Environmental Health Sciences.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

First Look at ‘Wasabi Receptor’ Brings Insights for Pain Drug Development
Protein’s structure will guide hunt for new treatments of inflammation-induced pain.
Tuesday, April 14, 2015
Mix of Bacteria in Gut May Depend More on Diet than Genes
Microbiota, microbiome change quickly, UCSF researchers find.
Wednesday, December 24, 2014
Dozens of Genes Associated with Autism in New Research
Functions of newly identified genes converge on a few important biological processes.
Saturday, November 01, 2014
Precise Control Over Genes Results from Game-Changing Research
UCSF invention greatly amplifies power of CRISPR technology.
Tuesday, October 14, 2014
Study Underscores Truvada’s Potency in Preventing the Transmission of HIV
New research from an international team of HIV/AIDS experts has reaffirmed the effectiveness of Truvada — the first and only medication approved by the FDA for HIV prevention.
Friday, September 14, 2012
Immunological Genome Project Researchers Probe Every Type of Immune Cell
The project aims to identify new strategies for orchestrating immune responses to better fight disease.
Thursday, August 30, 2012
Arthritis Drugs could Help Prevent Memory Loss After Surgery, Study Suggests
UCSF research also reveals that a specific inflammatory response in the brain may explain why many patients experience memory loss after surgery or critical illness.
Tuesday, November 02, 2010
UCSF Enters Drug Discovery Agreement with Genentech
The agreement aims to discover and develop drug candidates for neurodegenerative diseases.
Monday, February 22, 2010
NIH Stem Cell Guidelines Should be Modified, UCSF Team Reports
The team urge that guidelines be modified to better protect the rights of individuals donating egg or sperm to patients undergoing in vitro fertilization.
Monday, February 22, 2010
Identify Strategies to Protect New Brain Cells Against Alzheimer's Disease
Reversing abnormal brain activity in Alzheimer models improves development of new nerve cells born in adult brains.
Friday, December 04, 2009
Study Reveals Benefit of Adult Stem Cells for Acute Lung Injury
UCSF scientists have demonstrated that adult human mesenchymal stem cells reverse the effects of injury in a novel human lung preparation in the lab.
Thursday, September 03, 2009
UCSF Team Closer to Creating Safe Embryonic-Like Stem Cells
Researchers have for the first time used microRNAs to help turn adult mouse cells back to their embryonic state.
Tuesday, April 14, 2009
The Broad Foundation Donates $25 Million to UCSF Stem Cell Program
The funds will be used for constructing a headquarters for the program to enhance scientists’ efforts to develop treatments for a wide range of diseases.
Thursday, December 18, 2008
Genetic Markers Identified for Alcohol Response in UCSF Gallo Study
Researchers identify a genetic marker that appears to determine how strongly drinkers feel the effects of alcohol and thus how prone they are to alcohol abuse.
Thursday, December 11, 2008
Search for Genetic Clues to Breast Cancer in Hispanic Women
UCSF researchers are looking more deeply into the Hispanic women’s DNA to find out the genetic side of the breast cancer equation.
Thursday, December 11, 2008
Scientific News
Study Finds Brain Chemicals that Keep Wakefulness in Check
Researchers to develop new drugs that promote better sleep, or control hyperactivity in people with mania.
Sorting Through Cellular Statistics
Aaron Dinner, professor in chemistry, and his graduate student Herman Gudjonson are trying to read the manual of life, DNA, as part of the Dinner group’s research into bioinformatics—the application of statistics to biological research.
Playing 'Tag' with Pollution lets Scientists See Who's It
Using a climate model that can tag sources of soot from different global regions and can track where it lands on the Tibetan Plateau, researchers have determined which areas around the plateau contribute the most soot — and where.
Women’s Immune System Genes Operate Differently from Men’s
A new technology reveals that immune system genes switch on and off differently in women and men, and the source of that variation is not primarily in the DNA.
Long Telomeres Associated with Increased Lung Cancer Risk
Genetic predisposition for long telomeres predicts increased lung adenocarcinoma risk.
First Artificial Ribosome Designed
Researchers at the University of Illinois at Chicago and Northwestern University have engineered a tethered ribosome that works nearly as well as the authentic cellular component, or organelle, that produces all the proteins and enzymes within the cell.
High-Resolution 3D Images Reveal the Muscle Mitochondrial Power Grid
NIH mouse study overturns scientific ideas on energy distribution in muscle.
Expanding the Brain
A team of researchers has identified more than 40 new “imprinted” genes, in which either the maternal or paternal copy of a gene is expressed while the other is silenced.
Identifying a Key Growth Factor in Cell Proliferation
Researchers discover that aspartate is a limiter of cell proliferation.
Study Uncovers Target for Preventing Huntington’s Disease
Scientists from Cardiff University believe that a treatment to prevent or delay the symptoms of Huntington’s disease could now be much closer, following a major breakthrough.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!